Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile chronic myelogenous leukemia

J L Hess1, M M Zutter, R P Castleberry

  • 1Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

American Journal of Clinical Pathology
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why is there selective subcortical vulnerability in ADHD? Clues from postmortem brain gene expression data.

Molecular psychiatry·2017
Same author

Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.

Psychological medicine·2017
Same author

Genetics of Schizophrenia: Historical Insights and Prevailing Evidence.

Advances in genetics·2016
Same author

A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples.

Molecular psychiatry·2015
Same author

Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.

Oncogene·2015
Same author

Myocardial extramedullary hematopoiesis following myocardial infarction.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015

Juvenile chronic myelogenous leukemia (JCML) is a challenging childhood blood cancer. Diagnosis requires careful evaluation of clinical, pathological, and laboratory findings due to the absence of a specific marker chromosome.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Molecular Biology

Background:

  • Juvenile chronic myelogenous leukemia (JCML) is an aggressive childhood myeloproliferative disorder.
  • JCML presents distinct clinical and pathological features compared to adult Philadelphia chromosome-positive CML and other adult myeloproliferative neoplasms.
  • The disease shares characteristics with monosomy 7 syndrome and chronic myelomonocytic leukemia, complicating diagnosis.

Observation:

  • The absence of a specific marker chromosome makes diagnosing JCML difficult.
  • Diagnosis depends on a comprehensive assessment of clinical, pathological, and laboratory findings.
  • Clinical presentations of JCML can be highly variable.

Findings:

  • This review emphasizes pathological findings and laboratory data crucial for confirming JCML diagnosis.

Related Experiment Videos

  • The sensitivity, specificity, and clinical utility of cell culture colony assays are critically evaluated.
  • Current understanding of JCML biology and ongoing controversies are discussed.

    • Implications:

    • Accurate diagnosis of JCML is essential for appropriate management and treatment strategies.
    • Understanding JCML biology may lead to targeted therapies and improved patient outcomes.
    • Further research is needed to resolve controversies and refine diagnostic approaches for JCML.